Graduate School, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Division of New Health Technology Assessment, National Evidence-Based Healthcare Collaborating Agency, 400 Neungdong-ro, Gwangjin-gu, Seoul, 04554, Korea.
Support Care Cancer. 2022 Nov;30(11):9019-9027. doi: 10.1007/s00520-022-07315-9. Epub 2022 Aug 10.
Treatment for hematological malignancies (HMs) and functional decline associated with age can cause distress in elderly patients with HMs. However, information about the nature and effects of distress in this population is scarce. Therefore, this study examined the level of distress, its source, and the practical/familial/physical/emotional problems among elderly patients with HMs.
We conducted a cross-sectional study of patients with HMs aged ≥ 65 years who visited an outpatient clinic at a tertiary medical center in Korea between November 2019 and March 2020. Patient-reported distress and problems were measured using the distress thermometer (DT) and 39-item Problem List by the National Comprehensive Cancer Network. Descriptive statistics, χ test or Fisher's exact test, and multivariate logistic regression analyses were conducted (N = 132).
In total, 62.1% of patients had moderate to severe distress (DT score ≥ 4), experiencing an average of nine problems. Significant sources of distress on multivariate logistic analysis included problems with transportation, depression, and constipation, accounting for 47% of distress variance. Most patients had physical (97.0%) or emotional problems (79.5%). Among these, fatigue (60.6%), worry (59.8%), tingling (59.8%), difficulty with mobility (47.0%), and memory/concentration (40.2%) were the most frequently reported problems.
Elderly patients with HMs have a high burden of distress, which is affected by different sources, compared with younger patients with solid tumors. Thus, in this population, assessment and management of distress need to be conducted considering the unique features of their source and burden. Further research on distress should consider the cancer type and population age.
血液系统恶性肿瘤(HMs)的治疗以及与年龄相关的功能下降可导致老年 HM 患者痛苦。然而,有关该人群痛苦的性质和影响的信息却很少。因此,本研究调查了老年 HM 患者的痛苦程度、痛苦来源以及实际/家庭/身体/情绪问题。
我们对 2019 年 11 月至 2020 年 3 月期间在韩国一家三级医疗中心的门诊就诊的年龄≥65 岁的 HM 患者进行了横断面研究。患者报告的痛苦和问题使用痛苦温度计(DT)和国家综合癌症网络的 39 项问题清单进行测量。采用描述性统计、χ 检验或 Fisher 确切检验和多变量逻辑回归分析(N=132)。
共有 62.1%的患者有中度至重度痛苦(DT 评分≥4),平均经历了 9 个问题。多变量逻辑分析中,导致痛苦的主要原因包括交通问题、抑郁和便秘,占痛苦方差的 47%。大多数患者存在身体(97.0%)或情绪问题(79.5%)。在这些问题中,疲劳(60.6%)、担忧(59.8%)、刺痛(59.8%)、活动困难(47.0%)和记忆力/注意力集中(40.2%)是最常报告的问题。
与年轻的实体瘤患者相比,老年 HM 患者的痛苦负担更高,而且痛苦的来源也不同。因此,在这一人群中,评估和管理痛苦需要考虑其来源和负担的独特特征。进一步的痛苦研究应考虑癌症类型和人群年龄。